Want to see SE:ARCOMA full AI Analyst Report?

Arcoma AB (ARCOMA) Price & Analysis

0 Followers

ARCOMA Stock Chart & Stats

kr7.20

-kr0.40(-3.79%)

At close: Mar 06 4:00 PM EST

kr7.20

-kr0.40(-3.79%)

Day’s Range― - ―

52-Week Rangekr6.16 - kr11.00

Previous CloseN/A

Volume10.05K

Average Volume (3M)22.73K

Market Cap

kr117.62M

Enterprise Valuekr101.42M

Total Cash (Recent Filing)kr33.94M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)32.4

Beta0.19

Next Earnings

Aug 20, 2026

EPS Estimate

0.14

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.26

Shares Outstanding14,308,510

10 Day Avg. Volume31,356

30 Day Avg. Volume22,732

Financial Highlights & Ratios

PEG Ratio-0.36

Price to Book (P/B)1.41

Price to Sales (P/S)0.80

P/FCF Ratio5.68

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.55

Revenue Forecast (FY)kr135.00M

Bulls Say, Bears Say

Bulls Say

Balance Sheet Strength (zero Debt)Zero debt and a solid equity base materially reduce financial risk and preserve strategic optionality over the next several months. For a capital‑equipment business, debt-free financing supports investments in product development, service coverage, or targeted M&A without straining cash flow.

Robust Cash GenerationSustained operating and free cash flow provides durable internal funding for R&D, service expansion, and working capital for equipment deliveries. Strong cash conversion also cushions the business against lumpy order timing typical in medical equipment sales.

Installed-base & Recurring Service RevenueA business model combining capital sales with recurring service and parts creates durable revenue streams and customer stickiness. The installed base, long equipment lifecycles, and service contracts enhance revenue visibility and margin durability over multiple years.

Bears Say

Declining Revenue TrendMaterial negative revenue growth weakens the company's scale and may indicate demand softness or share erosion. In a capital‑equipment market where deliveries are lumpy, sustained declines reduce installed‑base growth and constrain long‑term service revenue and investment capacity.

Volatile Margins And ProfitabilityLarge year‑to‑year swings in gross margin and profitability reduce earnings predictability and complicate budgeting for R&D and service investments. Persistent margin volatility can signal pricing pressure, cost control issues, or product mix instability that harm long‑term returns.

Small Scale And Limited ResourcesA very small employee base limits sales reach, international rollout, and service capacity—critical for medical equipment adoption and ongoing support. Limited scale raises execution risk in scaling installations, regulatory compliance, and sustaining competitive product development.

ARCOMA FAQ

What was Arcoma AB’s price range in the past 12 months?

Arcoma AB lowest stock price was kr6.16 and its highest was kr11.00 in the past 12 months.

What is Arcoma AB’s market cap?

Arcoma AB’s market cap is kr117.62M.

When is Arcoma AB’s upcoming earnings report date?

Arcoma AB’s upcoming earnings report date is Aug 20, 2026 which is in 43 days.

How were Arcoma AB’s earnings last quarter?

Arcoma AB released its earnings results on Apr 23, 2026. The company reported kr0.057 earnings per share for the quarter, missing the consensus estimate of kr0.18 by -kr0.123.

Is Arcoma AB overvalued?

According to Wall Street analysts Arcoma AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Arcoma AB pay dividends?

Arcoma AB does not currently pay dividends.

What is Arcoma AB’s EPS estimate?

Arcoma AB’s EPS estimate is 0.14.

How many shares outstanding does Arcoma AB have?

Arcoma AB has 14,308,510 shares outstanding.

What happened to Arcoma AB’s price movement after its last earnings report?

Arcoma AB reported an EPS of kr0.057 in its last earnings report, missing expectations of kr0.18. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Arcoma AB?

Currently, no hedge funds are holding shares in SE:ARCOMA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Arcoma AB

Arcoma AB is a global provider that designs, manufactures, and supplies cutting-edge radiology solutions. Their product line features advanced digital x-ray and radiography systems. These versatile systems are suitable for a wide array of radiographic applications and are utilized across various clinical environments, including general practice, musculoskeletal, thoracic, pediatric, and trauma/resuscitation units. The company distributes its products through a network of OEM partners. Arcoma AB was founded in 1990 and is headquartered in Växjö, Sweden.